1,425 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
GET TESTED INTERNATIONAL AB recalled 76 units of its Allergy Test on November 3, 2025. The recall occurred due to distribution without premarket approval. Patients and healthcare providers should stop using the device immediately.
GET TESTED INTERNATIONAL AB recalled 148 units of its Diabetes HbA1c Test on November 3, 2025. The recall stems from distribution without premarket approval. Patients and healthcare providers must stop using the device immediately.
GET TESTED INTERNATIONAL AB recalled 109 units of its Candida Test on November 3, 2025. The recall stems from distribution without premarket approval or clearance. Patients and healthcare providers should stop using this device immediately.
GET TESTED INTERNATIONAL AB recalled 19 units of its Allergy Test on November 3, 2025. The recall stems from distribution without premarket approval or clearance. Patients and healthcare providers must stop using the device immediately.
GET TESTED INTERNATIONAL AB recalled 16 units of Food Intolerance Test Medium on November 3, 2025. The recall stems from distribution without premarket approval. Consumers should stop use immediately and follow provided instructions.
GET TESTED INTERNATIONAL AB recalled 36 units of the NAD Profile Test on November 3, 2025. The recall was issued due to distribution without premarket approval. Patients and healthcare providers should stop using this device immediately.
Orthofix U.S. LLC recalled 14,201 units of the Forza Ti Spacer System on November 3, 2025. The recall stems from inconsistent labeling claims that may mislead users. Patients and healthcare providers should stop using the product immediately and follow recall instructions.
GET TESTED INTERNATIONAL AB recalled eight units of the Fructose Intolerance Test on November 3, 2025. The recall occurs due to distribution without premarket approval. Patients and healthcare providers should stop using the device immediately.
Medtronic MiniMed recalled 577 units of the MiniMed 780G insulin pump on November 2, 2025. A software flaw in version 6.60 may cause insulin delivery to suspend unexpectedly, posing serious health risks. Patients should stop using the device immediately and follow recall instructions.
Philips North America recalled 1,913,441 IntelliVue Patient Monitors on October 31, 2025. A potential issue causes the monitors to fail to alarm, posing serious risks to patient safety. Consumers and healthcare providers should stop using these devices immediately and follow recall instructions.
Philips North America recalled 1,913,441 IntelliVue MP2 monitors on October 31, 2025. The monitors may not alarm as intended, posing a risk to patient safety. Affected devices were distributed worldwide, including the United States and multiple countries.
Philips North America recalled 1,913,441 IntelliVue MP90 monitors on October 31, 2025. The monitors may fail to alarm, posing a high risk to patient safety. Users must stop using the devices immediately and follow manufacturer instructions for remedy.
Philips North America recalled 1,913,441 IntelliVue Patient Monitors on October 31, 2025. The monitors may fail to alarm, posing serious risks to patients. Users must stop using the device immediately and follow the manufacturer's instructions.
Trifecta Pharmaceuticals USA recalled 12,150 bottles of Globe Clotrimazole Cream on October 31, 2025. The recall stems from deviations in current Good Manufacturing Practices (cGMP). Consumers should stop using the cream immediately and contact their healthcare providers.
Nivagen Pharmaceuticals recalled 7,920 bottles of Zinc Oxide Ointment on October 31, 2025. The recall follows cGMP deviations that could impact product safety. Consumers should cease use immediately and consult healthcare providers for advice.
Dyrnarex Corporation recalled 1,560 containers of Dynashield Skin Protectant on October 31, 2025. The product may not meet current Good Manufacturing Practice standards. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Dynarex Corporation recalled 2,400 containers of Wecare Calasoothe on October 31, 2025, due to cGMP deviations. The recall affects the 4 oz ointment, as it may not meet safety standards. Consumers should stop using the product immediately and consult their healthcare providers.
Blossom Pharmaceuticals recalled 9,600 containers of Lanashield Skin Barrier on October 31, 2025 due to cGMP deviations. Consumers and healthcare providers should stop using the product immediately. The recall affects products distributed nationwide in the USA.
Philips Ultrasound recalled 4,819 diagnostic ultrasound systems on October 31, 2025. The recall affects models 795005, 795161, and 989605449841 due to compatibility issues with Apple devices running iOS 18. These issues may prevent the systems from performing live imaging, posing risks in medical settings.
Aizu Olympus recalled 6,578 OER-Elite medical devices following safety concerns. The recall, announced on October 31, 2025, urges patients and healthcare providers to stop using the device immediately. Repairs should only be conducted by trained personnel to ensure safety.
Philips North America recalled 1,913,441 IntelliVue Patient Monitors on October 31, 2025. The monitors may fail to alarm, posing a serious risk to patients. Healthcare providers and patients must stop using these devices immediately.
Philips North America recalled 1,913,441 IntelliVue MP5 monitors on October 31, 2025, due to a failure to alarm. The recall affects devices distributed worldwide, including the United States. Patients and healthcare providers must stop using the monitors immediately.
Philips North America recalled 1,913,441 IntelliVue Multi Measurement Servers on October 31, 2025. These devices may fail to alarm, posing a serious risk to patient safety. Users should stop using the device immediately and follow recall instructions.
Philips North America recalled 1,913,441 IntelliVue MP30 monitors on October 31, 2025. The devices may fail to alarm, posing a serious risk to patients. Users must stop using the monitors and follow recall instructions immediately.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.